24/7 Market News Snapshot 15 July, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)
DENVER, Colo., 15 July, 2025 (www.247marketnews.com) – (NASDAQ:INBS) are discussed in this article.
Intelligent Bio Solutions Inc. (NASDAQ:INBS) has witnessed an impressive start today, opening at $1.81 and currently trading at $1.93, reflecting a notable gain of roughly 11.56% from the previous close of $1.73. This surge in stock price aligns with an increased trading volume of 577.72K shares, signaling robust investor interest and potential upward momentum. The stock appears to be breaking out of a recent consolidation phase, which could attract additional buyers. Market observers should keep an eye on resistance levels close to $2.00 while considering broader market influences that might affect overall performance.
In a significant development, Intelligent Bio Solutions has introduced the SmarTest® Patch, a cutting-edge non-invasive drug testing solution. This innovative wearable device, developed by SMARTOX®, is designed to continuously monitor substances, including cocaine, opiates, methamphetamines, marijuana, and fentanyl, through sweat analysis over a 7 to 10-day period. The SmarTest Patch enhances the Company’s diverse portfolio, complementing its established Intelligent Fingerprinting Drug Testing Solution and offering customers an expanded range of detection capabilities.
Doug Heath, Vice President of Global Sales, expressed enthusiasm about this launch, highlighting its potential to meet the needs for extended drug detection and demonstrating the Company’s commitment to advancing technological solutions. The patch’s user-friendly, water-resistant, and tamper-evident design makes it an effective option for justice and rehabilitation sectors, providing a discreet, pain-free testing experience.
This latest innovation not only strengthens Intelligent Bio Solutions’ product lineup but also reinforces its competitive position within the expanding market for non-invasive drug testing, catering to diverse customer requirements for both short- and long-term substance monitoring.
Related news for (INBS)
- Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
- 24/7 Market News Snapshot 16 July, 2025 – Intelligent Bio Solutions Inc. Common Stock (NASDAQ:INBS)
- Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
- Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion